NCPC(SH:600812) Ge Long Hui A P P·2025-11-04 09:07Core Viewpoint - Company Huabei Pharmaceutical has received approval from the National Medical Products Administration for the marketing application of Cefotolan Pivoxil, a third-generation cephalosporin antibiotic [1] Group 1: Product Approval - Huabei Pharmaceutical's wholly-owned subsidiary, Hebei Huamin Pharmaceutical Co., Ltd., has been granted the marketing approval for Cefotolan Pivoxil [1] - Cefotolan Pivoxil is a third-generation cephalosporin antibiotic that is hydrolyzed into the active form Cefotolan after absorption [1] Group 2: Antibacterial Efficacy - Cefotolan Pivoxil shows significant effectiveness against five major pathogens causing community-acquired respiratory infections, particularly against penicillin-resistant Streptococcus pneumoniae and Staphylococcus aureus [1] - The drug is suitable for treating infections caused by sensitive bacteria, including superficial and deep skin infections, lymphangitis, chronic pyoderma, and various respiratory infections [1]